Simpson Thacher represented the underwriters, led by J.P. Morgan Securities LLC, Credit Suisse (USA) LLC, Goldman Sachs & Co LLC and Jefferies LLC, in connection with the initial public offering by Sotera Health Company of 53,590,000 shares of its common stock, which raised approximately $1.2 billion in gross proceeds. The initial public offering closed on November 24, 2020.
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses–Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
The Simpson Thacher team for this transaction included Art Robinson, Jean Park, Kirsten Harmon, Arielle Trapp and Simone Worthy (Capital Markets); Vanessa Burrows (Healthcare); Mike Isby (Environmental); Andrew Blau and Pasco Struhs (Executive Compensation and Employee Benefits); Jennifer Nadborny and Joia Lee (Public Company Advisory Practice); Jonathan Cantor (Tax); Andrew Pagliughi (FINRA & Blue Sky); and Alysha Sekhon (IP).